No Data
No Data
2024 Semi-Annual Report
2024 Semi-Annual Report Summary
Beijing Labtech Instruments (688056.SH): Plans to use up to 140 million yuan of idle raised funds for cash management.
On August 8th, Gelon Hui reported that Beijing Labtech Instruments (688056.SH) plans to use up to RMB 140 million (including the principal) of the unused funds raised for cash management, with a usage period of not more than 12 months. Within the above-mentioned limit and period, the funds can be rolled over for use.
Beijing Labtech Instruments (688056.SH): Did not buy back company shares in July.
On July 2024, Beijing Labtech Instruments (stock code: 688056.SH) failed to repurchase its shares through the Shanghai Stock Exchange trading system by means of centralized bidding trading. As of 31 July 2024, the company has repurchased a total of 674,222 shares of the company through the Shanghai Stock Exchange trading system by centralized bidding trading, accounting for 1.0028% of the total share capital of the company, with a highest fill price of 27.37 yuan per share, a lowest fill price of 22.75 yuan per share and a total amount paid of RMB 1700.6.
Beijing Labtech Instruments (688056.SH): Currently, the company's ICP-MS products have achieved sales in the medical industry.
Labtech Instruments (Beijing) recently stated during a reception for institutional investors that their ICP-MS product can be used in the medical field, mainly for the detection of constant elements, trace nutrients, heavy metals, and drug concentrations in biological samples such as blood, urine, and hair. The product can be sold as medical diagnostic instruments and research instruments to hospitals and medical research institutions. However, applying it as a medical diagnostic instrument requires an application for a medical instruments registration certificate. Currently, the company's ICP-MS products have been sold in the medical industry and are being further promoted.
Beijing Labtech Instruments (688056.SH): has accumulated repurchased 1.0028% of the company's shares.
On July 2nd, Gelunhui reported that Beijing Labtech Instruments (688056.SH) has repurchased a total of 674,222 shares of the company through the Shanghai Stock Exchange trading system through centralized bidding trading method as of June 30, 2024. This accounts for 1.0028% of the company's current total share capital of 67,236,400 shares. The highest transaction price was 27.37 yuan/share, and the lowest transaction price was 22.75 yuan/share. The total amount paid was CNY 17,006,700 (excluding transaction fees such as stamp duty and commission).
No Data
No Data